CERo Therapeutics, Inc. is a new cellular immunotherapy company.
CERo Therapeutics, Inc. is a new cellular immunotherapy company. We have created a hybrid platform that integrates innate and adaptive programs to eliminate disease.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 18, 2020 | Series A | $40M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Lyell Immunopharma | — | Series A |
ARCH Venture Partners | — | Series A |